dm+d

96283003

Articles

Can oral bisphosphonates be given to people with renal impairment to treat osteoporosis?

9 July 2020In the main, bisphosphonates are not metabolised and are excreted unchanged in urine. Oral bisphosphonates are licensed for the primary and secondary prevention of osteoporotic…
Search Articles

Medicine Compliance Aid Stability

BonefosBayer plc

Bayer plc
Bonefos
Capsules 400mg. Tablets f/c 800mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
No special precautions for storage. However complex administration regime makes it unsuitable for MCA.
27 February 2015

ClasteonBeacon Pharmaceuticals

Beacon Pharmaceuticals
Clasteon
Capsules 400mg. Tablets f/c 800mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
No special precautions for storage. However complex administration regime makes it unsuitable for MCA.
27 February 2015

LoronIntrapharm Laboratories Ltd

Intrapharm Laboratories Ltd
Loron
Tablets 520mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
No special precautions for storage. However complex administration regime makes it unsuitable for MCA.
16 March 2015